Home > SWOT Analysis > ImmunoGen (IMGN) SWOT Analysis





ImmunoGen (IMGN) SWOT Analysis Profile

ImmunoGen, Inc, founded in 1981, researches and develops antibody-based anticancer therapeutics. The companys Tumor-Activated Prodrug (TAP) Technology uses antibodies to deliver a potent cytotoxic agent for the treatment of various cancers including gastric, pancreatic, colorectal, multiple myeloma, ovarian, and neuroendocrine. Based in Waltham, Massachussetts, ImmunoGen collaborates with a number of pharmaceutical and research companies. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 0

Threats + Weaknesses = 1

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties.